The role of the C-C chemokine receptor 2 gene polymorphism V641 (CCR2- 641) in sarcoidosis in a Japanese population

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 6, 1999, Pages 2021-2023

  Hizawa, Nobuyuki ^a   Yamacuchi, Etsuro ^a   Furuya, Ken ^a   Jinushi, Eisei ^a   Ito, Akihide ^a   Kawakami, Yoshikazu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; UNCLASSIFIED DRUG;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; JAPAN; LUNG ALVEOLUS CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR GENE; RISK FACTOR; SARCOIDOSIS;

EID: 0033065336     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.6.9810020     Document Type: Article

References (26)

1. 1. Luster, A. D. 1998. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
2. 2. Kodama, N., E. Yamaguchi, N. Hizawa, K. Furuya, J. Kojima, M. Oguri, T. Takahashi, and Y. Kawakami. 1998. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases. Am. J. Respir. Cell Mol. Biol. 18:526-531.
3. 3. Taub, D. D., and J. J. Oppenheim. 1994. Chemokines, inflammation and the immune system. Ther. Immunol. 1:229-246.
4. 4. Baumer, I., G. Zissel, M. Schlaak, and J. Muller-Quernheim. 1997. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am. J. Respir. Cell Mol. Biol. 16:171-177.
5. 5. Loetscher, P., M. Uguccioni, L. Bordori, M. Baggiolini, B. Moser, C. Chizzolini, and J.-M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391:344-345.
6. 6. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005-2007.
7. 7. Frade, J. M. R., M. Llorente, M. Mellado, J. Alcami, J. C. Gutierrez-Ramos, A. Zaballos, G. Real, and A. C. Martinez. 1997. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J. Clin. Invest. 100:497-502.
8. 8. Anzala, A. O., T. B. Ball, T. Rostron, S. J. O'Brien, F. A. Plummer, S. L. Rowland-Jones, and University of Nairobi Collaboration for HIV Research. 1998. CCR2-64I allele and genotype association with delayed AIDS progression in African women. Lancet 351:1632-1633.
9. 9. Kostrikis, L. G., Y. Huang, J. P. Moore, S. M. Wolinsky, L. Zhang, Y. Guo, L. Deutsch, J. Phair, A. U. Neumann, and D. D. Ho. 1998. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med. 4: 350-353.
10. 10. Smith, M. W., M. Dean, M. Carrington, C. Winkler, G. A. Huttley, D. A. Lomb, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov, K. Hoots, M. W. Hilgartner, and S. J. O'Brien. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-965.
11. 11. Newman, L. S., C. S. Rose, and L. A. Maier. 1997. Sarcoidosis. N. Engl. J. Med. 336:1224-1234.
12. 12. Kunikane, H., S. Abe, Y. Tsuneta, T. Nakayama, Y. Tajima, J. Misonou, A. Wakisaka, M. Aizawa, and Y. Kawakami. 1987. Role of HLA-DR antigens in Japanese patients with sarcoidosis. Am. Rev. Respir. Dis. 135: 688-691.
13. 13. Berlin, M., A. Fogdell-Hahn, O. Olerup, A. Eklund, and J. Grunewald. 1997. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 156:1601-1605.
14. 14. Furuya, K., E. Yamaguchi, A. Itoh, N. Hizawa, N. Ohnuma, J. Kojima, N. Kodama, and Y. Kawakami. 1996. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 51:777-780.
15. 15. Seitzer, U., C. Swider, F. Stuber, K. Suchnicki, A. Lange, E. Richter, P. Zabel, J. Muller-Quernheim, H. D. Flad, and J. Gerdes. 1997. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 9:787-790.
16. 16. Boring, L., J. Gosling, S. W. Chensue, S. L. Kunkel, R. V. Farese, H. E. Broxmeyer, and I. F. Charo. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552-2561.
17. 17. Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. U.S.A 94:12053-12058.
18. 18. Dawson, S. J., P. J. Morris, and D. S. Latchman. 1996. A single amino acid change converts an inhibitory transcription factor into an activator. J. Biol. Chem. 271:11631-11633.
19. 19. Lee, B., B. J. Doranz, S. Rana, Y. Yi, M. Mellado, J. M. R. Frade, C. Martinez-A, S. J. O'Brien, M. Dean, R. G. Collman, and R. W. Doms. 1998. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J. Virol. 72:7450-7458.
20. 20. Samson, M., P. Soularue, G. Vassart, and M. Parmentier. 1996. The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 36:522-526.
21. 21. Ansari-Lari, M. A., X.-M. Liu, M. L. Metzker, A. R. Rut, and R. A. Gibbs. 1997. The extent of genetic variation in the CCR5 gene. Nature Genet. 16:221-222.
22. 22. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862.
23. 23. Martinson, J. J., N. H. Chapman, D. C. Rees, Y.-T. Liu, and J. B. Clegg. 1997. Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet. 16:100-103.
24. 24. Brenitz, E. A., and B. L. Strom. 1983. Epidemiology of sarcoidosis. Epidemiol. Rev. 5:124-156.
25. 25. Harrington, D. W., M. Major, M. Rybicki, M. Maliarik, and M. C. Iannuzzi. 1993. Familial sarcoidosis: analysis of 91 families. Sarcoidosis 11:210-243.
26. 26. Maliarik, M. J., B. A. Rybicki, E. Malvitz, R. G. Sheffer, M. Major, J. Popovich, Jr., and M. C. Iannuzzi. 1998. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am. J. Respir. Crit. Care Med. 158:1566-1570.